Last Monday (11 May), QuintilesIMS UK and Teva UK scooped the coveted BOBI (Best of Business Intelligence) Award for Excellence in Business Analytics, beating strong competition in the field.
This was awarded for their project to design and deploy a first-in-class automated, standard data delivery platform, bringing impact and benefit to Teva UK’s Commercial Excellence team.
Run by BHBIA (British Healthcare Business Intelligence Association) and taking place this year at the Royal Garden Hotel, the awards are the first and only healthcare-specific business intelligence scheme in the UK, giving professionals the opportunity to gain peer recognition for excellence in business intelligence, market research and sales research and analytics.
Teva is a leading global pharmaceutical company committed to increasing access to quality health solutions, and delivers high-quality healthcare solutions to millions of patients every day.
Teva UK had undergone a significant change in the delivery of key insights following their move to Qlikview in 2014. This move enabled a far more automated approach, but one key difficulty was the retrieval of monthly and weekly QuintilesIMS data and moulding it into the shape required for this new reporting solution.
The organisation was also looking for a more automated integration of UK and subnational data into a central warehouse, and the ability to facilitate consolidated reporting and analytical needs across the organisation. In addition, Teva UK was looking to eliminate the need to check for inconsistencies and extra data quality checks during the process.
QuintilesIMS provided a piece of technology as a personalised, integrated solution to this problem: the MDM Sales Integrator. This tool enabled the automation of the process, the delivery of files in Qlikview format to the Teva UK servers, additional validation checks and manipulation of data formatted into a personalised style for the organisation.
Christian Griffin, Director, Commercial Excellence, Teva UK, said: “This programme has brought value to our organisation and allowed us to achieve greater efficiency savings, and deliver stronger reporting, data analytics and valuable market insight to customers.”
He added: “The way in which the Commercial Excellence team digest QuintilesIMS data has changed significantly. The team now has access to the most up-to-date data through the new tool.”
The BOBI judging panel said: “A complex business need was brought to life in this submission – and the entry demonstrated effective resolution through complex analytics and data automation, to reduce workload and increase coherence.”
Tim Sheppard, General Manager, QuintilesIMS UK & Ireland, commented: “This is only the start of the evolution for Teva UK. Teva UK’s Senior Management can now have their reports earlier than previously with the confidence that quality checks have been applied and KPIs can be understood quickly at a few clicks of a button.”
“The reporting backbone that has been created means the Commercial Excellence team can now utilise the same view of the data rather than independently creating their own visualisation of their specific markets. We are excited to be on this journey of growth with Teva UK.”